探索遗传结局作为衰弱生物标志物
该研究在老年人中比较衰弱、衰弱前期与非衰弱组的遗传结局,包括突变率、DNA损伤类型和细胞修复能力。结果显示突变率或原发性DNA损伤与衰弱无关,但磷酸化H2AX持续水平随衰弱严重程度逐渐升高,提示其可能用于反映衰弱严重程度。
要点
- 突变率或原发性DNA损伤与衰弱无关联。
- 磷酸化H2AX持续水平随衰弱严重程度增加而升高。
- DNA修复能力随衰弱下降呈非显著趋势。
核心结论
- 磷酸化H2AX持续水平可能提供衰弱严重程度的信息。
研究设计与样本
- 在老年人中按衰弱、衰弱前期和非衰弱分组,分析突变率、不同类型遗传损伤和细胞修复能力。
主要发现
- 突变率或原发性DNA损伤与衰弱无关联。
- DNA修复能力随衰弱呈非显著下降趋势。
- 磷酸化H2AX持续水平随衰弱严重程度逐渐升高。
临床怎么用
- 磷酸化H2AX可能作为反映衰弱严重程度的候选生物标志物,但需进一步验证。
局限性
- 需在不同人群和更大样本量中验证当前发现的一致性。
- 需标准化生物标志物以用于临床。
- 需充分理解认知障碍的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Frailty has emerged as a reliable measure of the aging process. Because the early detection of frailty is crucial to prevent or even revert it, the use of biomarkers would allow an earlier and more objective identification of frail individuals. To improve the understanding of the biological features associated with frailty as well as to explore different biomarkers for its early identification, several genetic outcomes-mutagenicity, different types of genetic damage, and cellular repair capacity-were analyzed in a population of older adults classified into frail, prefrail, and nonfrail. Besides, influence of clinical parameters-nutritional status and cognitive status-was evaluated. No association of mutation rate or primary DNA damage with frailty was observed. However, DNA repair capacity showed a nonsignificant tendency to decrease with frailty, and persistent levels of phosphorylated H2AX, as indicative of DNA breakage, increased progressively with frailty severity. These results support the possible use of H2AX phosphorylation to provide information regarding frailty severity. Further investigation is necessary to determine the consistency of the current findings in different populations and larger sample sizes, to eventually standardize biomarkers to be used in clinics, and to fully understand the influence of cognitive impairment.
引用
- Valdiglesias V, Sánchez-Flores M, Marcos-Pérez D, et al. Exploring Genetic Outcomes as Frailty Biomarkers. J Gerontol A Biol Sci Med Sci. 2019. PMID: 29684114. doi:10.1093/gerona/gly085
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。